Thais spend one-tenth of the day with YouTube

Thais spend one-tenth of the day with YouTube

Thai people spend an average of 2.4 hours watching YouTube each day, reflecting opportunities for brands and advertisers, says YouTube Thailand.

YouTube Thailand, an affiliate company of the world's top video streaming platform, reports that 46 million Thais watch YouTube.

People in urban areas average 2.4 hours a day and spend 70 minutes per visit, while those in rural areas spend 2.1 hours a day and 60 minutes per visit.

Ben King, Google Thailand's country director, said advertisers can generate business and strengthen their brands through YouTube, which has been owned by Google since 2006.

YouTube can effectively boost views by 3.5 times for advertisers compared with other social media platforms, Mr King said.

According to the latest research from YouTube and market research agency TNS, 62% of YouTube users in Thailand access the platform several times a day, and 75% access it daily.

Of total active YouTube users, 51% watch rerun TV content, 33% learn something new, 70% listen to music, and 24% search for information about products and services.

One billion YouTube hours are active daily globally, and there are 1.5 billion logged-in YouTube users every month, with 400 hours of content uploaded every minute.

YouTube has 80 localised languages in 90 countries.

Do you like the content of this article?

BTS, Taylor Swift beaten as Spotify’s most-streamed artist in Hong Kong

Canto-pop singer Eason Chan was the most-streamed artist in Hong Kong for the fifth consecutive year, streaming service Spotify revealed this week.


Another B43.5bn package to spur consumption

Another 43.5 billion baht will be allocated to boost domestic consumption and local travel, officials said on Wednesday, as the government tries to revive a flagging, pandemic-hit economy.


When and how will vaccines become available?

NEW YORK: Britain on Wednesday became the first Western country to approve a Covid-19 vaccine, jumping ahead of the United States and Europe after its regulator cleared a shot developed by Pfizer and BioNTech for emergency use in record time.